![Martine van Vugt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martine van Vugt
Director/Miembro de la Junta en SCANDION ONCOLOGY A/S .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Johnny Stilou | M | 57 | 3 años | |
Jan van de Winkel | M | 63 | 25 años | |
Deirdre Connelly | F | 63 | 7 años | |
Martin Møller | M | 49 | 3 años | |
Jørgen Vilhelm Bardenfleth | M | 69 | 6 años | |
Pernille Erenbjerg | F | 57 | 9 años | |
Jan Stenvang | M | - | 7 años | |
Anthony Pagano | M | 46 | 17 años | |
Susan Coles | F | 58 | 3 años | |
Paolo Augusto Paoletti | M | 73 | 9 años | |
Marisol Peron | F | - | 5 años | |
Keld Flintholm Jørgensen | M | 53 | 2 años | |
Elizabeth O'Farrell | F | 59 | 2 años | |
Alejandra Maria Mørk | M | 63 | 2 años | |
Rolf K. Hoffmann | M | 64 | 8 años | |
Maarten Ligtenberg | M | - |
Immagene BV
![]() Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | - |
Tahamtan Ahmadi | M | 51 | 7 años | |
Martin Schultz | M | 49 | 2 años | |
Takahiro Hamatani | M | 50 | 2 años | |
Nicky Vogels | F | - |
Immagene BV
![]() Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | - |
Christopher Cozic | M | 46 | - | |
Anthony Mancini | M | 53 | 4 años | |
Allard Kaptein | M | - |
Immagene BV
![]() Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | - |
Mijke Zachariasse | M | 51 | 5 años | |
Morten Nissen | M | - | - | |
Judith Klimovsky | M | 67 | 7 años | |
Shobhit Dhawan | M | - |
Immagene BV
![]() Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | - |
Birgitte Stephensen | F | 63 | 22 años | |
Andrew Carlsen | M | - | 5 años | |
François Martelet | M | 64 | 1 años | |
Anders Gersel Pedersen | M | 73 | 21 años | |
Lars Damstrup | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Estadísticas
País | Relaciones | % del total |
---|---|---|
Dinamarca | 71 | 88.75% |
Alemania | 5 | 6.25% |
Países Bajos | 4 | 5.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Martine van Vugt
- Red Personal